Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health Obesity management medications (OMMs) have exploded in popularity in recent years, a trend highlighted by the success of GLP-1 drugs such as semaglutide and tirzepatide
:
We hope you will stop by our complete Cheat Sheet Complete Library
- Ensure clinical documentation supports the drugs use, including diagnosis, treatment rationale, prior therapy history, and presence of organ or systems involvement, to justify billing and reimbursement
Class explains that unlike with a regular dose, the goal of a microdose isnt appetite shutdown
Common: Nausea, vomiting, diarrhea, decreased appetite, abdominal discomfort